-
The variant is "becoming the dominant strain in some parts of the country" such as Bolton and Blackburn, Xinhua news agency quoted hancock as saying to Sky News on Sunday.
-
The study was published on World Hypertension Day in the European Journal of Preventive Cardiology, it is a journal of the European Society of Cardiology (ESC).
-
Serves tasty, wholesome protein-rich food without using artificial colours, additives or sugar
-
For nuts, it's the fat content that leads them down the road to expiration.
-
These fungal spores are present in the air, soil and on decomposed debris and gain entry into sinuses and lungs by breathing contaminated air.
-
The decision-making process gets dominated by personal risk concerns. The best way to counter those concerns, therefore, is to highlight the opposite: personal benefits
-
Disease often manifests in skin and also affects lungs and brain
-
These were announced hrough video conferencing (VC) from SBI Local Head Office, Hyderabad. Narayanpet collector Hari Chandana, Vikarabad collector Pausumi Basu and Jogulamba Gadwal DMHO Chandu Naik
-
Shailendra Dubey , Chairman AIPEF said as many as 1,000 power sector employees and engineers have succumbed to Covid-19 and more than 15,000 have been infected from the virus.
-
The research was published in Nature Communications, a peer-reviewed, open access, scientific journal published by Nature Research. It could improve cancer therapies in the future for millions of people worldwide.
-
Having genetic risk variants in the ABO gene might significantly increase the chances of developing Covid-19, and other genes may also increase the risk, according to researchers
-
Factors such as vaccine hesitancy and mistaken beliefs about the risks COVID-19 poses to children may make this a challenging goal.
-
There has been no closure for me because I could neither bid them a final goodbye nor could I even see them for the last time.
-
"The 2-DG drug impacts the cells that are affected by coronavirus and prevent their multiplication. The drug will not affect the good cells," Rakesh Kumar Sharma said.
-
SARS-CoV-2, the virus behind Covid-19, spreads mainly through respiratory droplets, and dental procedures are known to produce an abundance of aerosols leading to fears that flying saliva
-
The study led by University of Oxford researchers, earlier this year, began to investigate the effect of alternate doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine.
-
The study published in the journal Clinical Nutrition examined the link between fruit and vegetable intake and stress levels of more than 8,600 Australians aged between 25 and 91 participating in the Australian Diabetes
-
The 12-16 weeks gap for Covishield will not only boos its efficacy but also help vaccine administration effectively and provide breathing space to the governments for improving supply
-
These conditions include a one dose vaccine effectiveness (efficacy) of 80 per cent or higher and vaccination rates of 0.1 per cent to 0.3 per cent of the population per day, according to the study, published by The BMJ.
-
The drug baricitinib has been granted a restricted emergency use approval in India by the Central Drugs Standard Control Organization (CDSCO) for emergency use in combination with remdesivir for the treatment of suspected or laboratory confirmed Covid-19
-
These conditions include a one dose vaccine effectiveness (efficacy) of 80 per cent or higher and vaccination rates of 0.1 per cent to 0.3 per cent of the population per day
-
The study was conducted with FAPESP's support by scientists affiliated with the University of Sao Paulo's Biomedical Sciences Institute (ICB-USP) and the Medical School of Santa Casa de Misericordia de Sao Paulo (FCM-SCMSP).
-
Covid-19 patients with a first-phase ejection fraction -- a measure of the left ventricular ejection fraction until the time of maximal ventricular contraction -- of less than 25 per cent had a nearly five-fold higher risk of death than those with an ejection fraction of 25 per cent or higher.
-
To deal with such a spread, vaccine makers will have to adapt and modify their shots over the coming years, Dr. Alan Bernstein, an expert on Canada government's Covid-19 Task Force